
ReCerise Signs Research Collaboration for Innovative Hepatocellular Carcinoma Treatment
ReCerise Signs Research Collaboration for Innovative Hepatocellular Carcinoma Treatment ReCerise Therapeutics Inc., a company focused on developing first-in-class oncology therapeutics, has announced a new research partnership with the National Cancer Centre Singapore (NCCS). The collaboration aims to create innovative treatments…












